The role of Epstein–Barr virus in nasopharyngeal carcinoma
Nasopharyngeal carcinoma (NPC) is a metastasis-prone malignancy closely associated
with the Epstein–Barr virus (EBV). Despite ubiquitous infection of EBV worldwide, NPC …
with the Epstein–Barr virus (EBV). Despite ubiquitous infection of EBV worldwide, NPC …
The role of EBV-encoded LMP1 in the NPC tumor microenvironment: from function to therapy
Nasopharyngeal carcinoma (NPC) is closely associated with Epstein-Barr virus (EBV)
infection. It is also characterized by heavy infiltration with non-malignant leucocytes. The …
infection. It is also characterized by heavy infiltration with non-malignant leucocytes. The …
Targeting Epstein-Barr virus in nasopharyngeal carcinoma
Nasopharyngeal carcinoma (NPC) is consistently associated with Epstein-Barr virus (EBV)
infection in regions in which it is endemic, including Southern China and Southeast Asia …
infection in regions in which it is endemic, including Southern China and Southeast Asia …
Cumulative roles for Epstein-Barr virus, human endogenous retroviruses, and human herpes virus-6 in driving an inflammatory cascade underlying MS pathogenesis
Roles for viral infections and aberrant immune responses in driving localized
neuroinflammation and neurodegeneration in multiple sclerosis (MS) are the focus of …
neuroinflammation and neurodegeneration in multiple sclerosis (MS) are the focus of …
Dual‐targeting peptide‐guided approach for precision delivery and cancer monitoring by using a safe upconversion nanoplatform
Abstract Using Epstein‐Barr virus (EBV)‐induced cancer cells and HeLa cells as a
comparative study model, a novel and safe dual‐EBV‐oncoproteins‐targeting pH …
comparative study model, a novel and safe dual‐EBV‐oncoproteins‐targeting pH …
Polymeric dendrimers as nanocarrier vectors for neurotheranostics
Dendrimers are polymers with well‐defined 3D branched structures that are vastly utilized in
various neurotheranostics and biomedical applications, particularly as nanocarrier vectors …
various neurotheranostics and biomedical applications, particularly as nanocarrier vectors …
[HTML][HTML] EBV latent membrane protein 1 augments γδ T cell cytotoxicity against nasopharyngeal carcinoma by induction of butyrophilin molecules
Y Liu, KS Lui, Z Ye, TY Fung, L Chen, PY Sit… - Theranostics, 2023 - ncbi.nlm.nih.gov
Nasopharyngeal carcinoma (NPC) is a diverse cancer with no well-defined tumor antigen,
associated with oncogenic Epstein-Barr Virus (EBV), and with usually late-stage diagnosis …
associated with oncogenic Epstein-Barr Virus (EBV), and with usually late-stage diagnosis …
EBNA1 inhibitors block proliferation of spontaneous lymphoblastoid cell lines from patients with multiple sclerosis and healthy controls
MCG Monaco, SS Soldan, C Su, A Clauze… - Neurology …, 2023 - AAN Enterprises
Background and Objectives Epstein-Barr virus (EBV) is a ubiquitous herpesvirus that
establishes lifelong latency in memory B cells and has been identified as a major risk factor …
establishes lifelong latency in memory B cells and has been identified as a major risk factor …
Lytic induction therapy Against Epstein–Barr virus-associated malignancies: Past, present, and future
Epstein–Barr virus (EBV) lytic induction therapy is an emerging virus-targeted therapeutic
approach that exploits the presence of EBV in tumor cells to confer specific killing effects …
approach that exploits the presence of EBV in tumor cells to confer specific killing effects …
Targeting Epstein–Barr virus in multiple sclerosis: when and how?
G Giovannoni - Current Opinion in Neurology, 2024 - journals.lww.com
EBV is the probable cause of MS and is likely to be driving MS disease activity via latent-lytic
infection cycling. There is evidence that all licensed MS disease-modifying therapies target …
infection cycling. There is evidence that all licensed MS disease-modifying therapies target …